DT

Diabetes Technology & Therapeutics

This peer-reviewed journal provides healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.

Looking to publish in Diabetes Technology & Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Endocrinology & Metabolism
Impact Factor 6.3
Quartile Q1
Open Access Type Hybrid
ISSN 1520-9156
eISSN 1557-8593
Invitation Only No
Cost Range Subscription journal with mandatory page charges of $90/page upon acceptance; optional open access publishing is available via Sage Choice for a fee.

Submission Instructions

Diabetes Technology & Therapeutics accepts the following article types. Click on an article type to view submission instructions.

Original Articles

Cover Letter Cover letter is required only if third-party writing or editing assistance was used or if the submission was made by someone not listed as an author. Cover letter must disclose any third-party writing or editing assistance and state if the submission was made on behalf of the authors by someone not listed as an author.
Abstract Structured abstract is required. Abstract must not exceed 300 words. Abstract must be structured.
Manuscript Manuscript must not exceed 5,000 words, excluding the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, and references. Manuscript must include clearly defined sections with clear heading levels, with the abstract placed between the title and the main body. Manuscript must include at least 4 keywords, an Author Contributions section after the Acknowledgements, a 'Statements and Declarations' section at the end of the article, and a graphical abstract image including the title, brief methods, results, conclusions, and a creator credit line.
References References must use Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, with identical spelling and year in corresponding citations.
Figures & Tables A maximum of 8 tables and/or figures is allowed. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Review Articles

Cover Letter A cover letter is required if third-party writing or editing assistance was used or if the submission was made on behalf of the authors by a non-author. The cover letter must disclose any third-party writing or editing assistance and whether the submission was made on behalf of the authors by someone who is not an author.
Abstract Review Articles must include an abstract. The abstract must be unstructured and no more than 300 words. The abstract must be unstructured.
Manuscript The manuscript must not exceed 6,000 words. The manuscript must include clearly defined sections with clear heading levels. The manuscript must include at least 4 keywords after the abstract, an Author Contributions section, a 'Statements and Declarations' section, and a graphical abstract image including the title, brief methods, results, conclusions, and a creator credit line.
References References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, with identical spelling and year in both places.
Figures & Tables Review Articles may include a maximum of eight tables and/or figures. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Brief Reports

Cover Letter A cover letter is required if writing or editing assistance from a third party was used or if submission was made on behalf of the authors by someone not listed as an author. The cover letter must disclose any third-party writing or editing assistance and state if the submission was made on behalf of the authors by a non-author.
Abstract Brief Reports must include an abstract. The abstract must be unstructured and no more than 150 words. The abstract must be unstructured.
Manuscript The manuscript must not exceed 2,000 words, excluding the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, and references. The manuscript must place the abstract between the title and the main body and include Acknowledgements, Author Contributions, and a final section headed 'Statements and Declarations'. The manuscript must include at least 4 keywords after the abstract and a graphical abstract image containing the title, brief methods, results, conclusions, and a creator credit line.
References References must follow Sage Vancouver style. Every in-text citation must have a matching reference list entry and vice versa, with identical spelling and year in corresponding citations.
Figures & Tables Brief Reports may include a maximum of one figure and one table. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Letters To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract must be included. The abstract may be structured or unstructured according to the format required for the article type.
Manuscript Letters To The Editor must not exceed 500 words. Sections must be clearly defined with clear heading levels. At least 4 keywords must follow the abstract, and the manuscript must include an Author Contributions section and a 'Statements and Declarations' section after the Acknowledgements section if applicable.
References Letters To The Editor must not exceed five references. References and citations must use Sage Vancouver style. Reference citations must be identical in style to those of full original articles, and every in-text citation must have a corresponding reference list entry and vice versa.
Figures & Tables Letters To The Editor may include one figure or one table.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Observational Letter

Cover Letter Any writing or editing assistance from a third party and any submission made by a non-author on behalf of the authors must be disclosed in the covering letter.
Abstract An abstract must be included. The abstract may be structured or unstructured according to the article type format.
Manuscript The manuscript must not exceed 750 words, excluding the abstract, disclosure statements, author contribution statements, funding information, acknowledgments, tables, figure legends, and references. Heading levels must be clear and sections clearly defined, with an Author Contributions section after the Acknowledgements and a final section headed 'Statements and Declarations.' At least 4 keywords must appear after the abstract, and the manuscript must include Author Contributions and a 'Statements and Declarations' section even when entries are marked 'Not applicable.'
References The article must not exceed five references. References must use Sage Vancouver style. Reference citations must follow the same style as full original articles, and every in-text citation must correspond exactly to a reference list entry and vice versa.
Figures & Tables The article may include one figure or one table. Figures must be numbered consecutively in the order in which they appear in the text.
Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Recent Publications

First Use of Control-IQ+ Technology in Newly Indicated Populations

Kimia Z. Assadi, Edwin W. D’Souza, Jordan E. Pinsker, Laurel H. Messer

10.1177/15209156261456818
View Publication

Early Assessment of Teplizumab Treatment Response Using Continuous Glucose Monitoring

Sari Krepel-Volsky, Merav Gil-Margolis, Keren Smuel-Zilberberg, Sarit Weizman, Moshe Phillip, Tal Oron

10.1177/15209156261458517
View Publication

Comparing Automated Lyumjev® Delivery with Carbohydrate Counting, Qualitative Meal-Size Estimation, and Fully Closed-Loop in Type 1 Diabetes: A Pilot, Randomized, Crossover Trial

Carolyne Schumacher, Michael A. Tsoukas, Laurent Legault, Melissa-Rosina Pasqua, Gabrielle Kemp, Elisa Cohen, Richard Jones, Eyal Dassau, Ahmad Haidar

10.1177/15209156261456440
View Publication

Glycemic Responses to Two Different Exercise Modalities in Adolescents with Type 1 Diabetes Using Automated Insulin Delivery Systems: The AIDing Exercise Study

Emilie B. Lindkvist, Olivia M. McCarthy, Sandra Tawfik, Michael Zaucha Sørensen, Richard M. Bracken, Ajenthen G. Ranjan, Jannet Svensson, Kirsten Nørgaard

10.1177/15209156261456820
View Publication

Temporary Target Use with Automated Insulin Delivery Is Associated with Longer and Safer Exercise in Adolescents with Type 1 Diabetes: A Post Hoc Analysis from the Fast Advanced Closed-Loop Therapy Study

Dessi P. Zaharieva, Simon Bergford, Natasa Bratina, Elke Fröhlich-Reiterer, Nejka Potočnik, Tim Hropot, Maria Fritsch, Peter Calhoun, Tadej Battelino, Klemen Dovč

10.1177/15209156261457755
View Publication

Frequently asked questions

How long does it take to publish?

Is a cover letter required?

A covering letter is required when writing or editing assistance from a third party is disclosed, when a submission is made on behalf of the authors by a non-author, and a confirmatory letter may be uploaded for consent to publish information.

Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

What are the publication costs?

Mandatory page charges are $90/page upon acceptance. Optional open access publishing is available for a fee via Sage Choice.

Reformat to Diabetes Technology & Therapeutics using Livewrite Premium

Research Topics

Diabetes Management and Research Pancreatic function and diabetes Diabetes and associated disorders Diabetes Treatment and Management Hyperglycemia and glycemic control in critically ill and hospitalized patients Diabetes Management and Education Metabolism, Diabetes, and Cancer Mobile Health and mHealth Applications Diabetes, Cardiovascular Risks, and Lipoproteins Diet and metabolism studies Gestational Diabetes Research and Management Spectroscopy Techniques in Biomedical and Chemical Research Electrochemical sensors and biosensors Heart Rate Variability and Autonomic Control Inhalation and Respiratory Drug Delivery Diabetic Foot Ulcer Assessment and Management Cardiovascular Function and Risk Factors Pharmacology and Obesity Treatment Pharmaceutical studies and practices Botulinum Toxin and Related Neurological Disorders Chronic Disease Management Strategies Natural Antidiabetic Agents Studies Advanced Glycation End Products research Adipose Tissue and Metabolism Medication Adherence and Compliance

Related Journals

Ps
Psychoneuroendocrinology Elsevier BV
TE
Tissue Engineering Part B Reviews Mary Ann Liebert, Inc.
AO
Annals of Pediatric Endocrinology & Metabolism Korean Society of Pediatric Endocrinology
BO
BMJ Open Diabetes Research & Care BMJ
NA
Nutrition and Diabetes Springer Nature
OR
Obesity Reviews WILEY